Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California

Cancer

Volumn 118, Issue 9, 2012, Pages 2516-2524

  Parise, Carol A ^a   Bauer, Katrina R ^b   Caggiano, Vincent ^a  

^a Sutter Institute for Medical Research   (United States)

^b PUBLIC HEALTH INSTITUTE   (United States)

Author keywords

adjuvant therapy; breast cancer; California Cancer Registry; geriatric population; healthcare disparities; race ethnicity; regional variation; socioeconomic status

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER REGISTRY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH DISPARITY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIAL STATUS; UNITED STATES;

AFRICAN AMERICANS; AGED; BREAST NEOPLASMS; CALIFORNIA; COMBINED MODALITY THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; REGISTRIES;

EID: 84860216468     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26542     Document Type: Article

References (56)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. American Cancer Society, California Department of Public Health, California Cancer Registry. California Facts and Figures 2011. Oakland, CA: American Cancer Society, California Division; 2010.
3. Campleman S, Curtis R,. Demographic aspects of breast cancer incidence and mortality in California, 1988-1999. In:, Morris C, Kwong, SL, eds. Breast Cancer in California, 2003. Sacramento, CA: California Department of Health Services, Cancer Surveillance Section; 2004: 19-28.
4. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA. 1991; 265: 391-395.
5. Katz SJ, Lantz PM, Janz NK, et al. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J Clin Oncol. 2005; 23: 3001-3007.
6. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 1227-1232.
7. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 1233-1241.
8. Chu KC, Miller BA, Springfield SA,. Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J Natl Med Assoc. 2007; 99: 1092-1100, 1102-1104.
9. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005; 97: 439-448.
10. Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover RN,. Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst. 1995; 87: 1846-1853.
11. Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS,. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992; 326: 1102-1107.
12. Baicker K, Chandra A, Skinner JS,. Geographic variation in health care and the problem of measuring racial disparities. Perspect Biol Med. 2005; 48 (1 suppl): S42-S53.
13. Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006; 24: 1357-1362.
14. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V,. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007; 109: 1721-1728.
15. Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V,. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004. Cancer. 2008; 112: 737-747.
16. Parise CA, Bauer KR, Brown MM, Caggiano V,. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. Breast J. 2009; 15: 593-602.
17. Parise CA, Bauer KR, Caggiano V,. Variation in breast cancer subtypes with age and race/ethnicity. Crit Rev Oncol Hematol. 2010; 76: 44-52.
18. Parise C, Bauer K, Caggiano V,. Disparities in the use of radiation therapy following breast conserving surgery in California. Abstract presented at: 2009 Breast Cancer Symposium; October 8-10, 2009; San Francisco, Calif. Abstract 140.
19. Fritz AG,. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000:vi, 239.
20. Cancer Reporting in California: Abstracting and Coding Procedures for Hospitals. California Cancer Reporting System Standards, vol I. Sacramento, CA: California Department of Public Health, Cancer Surveillance and Research Branch; 2008.
21. Bauer K, Parise C, Caggiano V,. Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer. BMC Cancer. 2010; 10: 228.
22. Christensen R,. Log-Linear Models and Logistic Regression. 2nd ed. New York, NY: Springer-Verlag; 1997.
23. Hosmer D, Lemeshow S,. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989.
24. Jatoi I, Anderson WF, Rao SR, Devesa SS,. Breast cancer trends among black and white women in the United States. J Clin Oncol. 2005; 23: 7836-7841.
25. Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID, Jatoi I,. Racial disparities in breast cancer outcome: insights into host-tumor interactions. Cancer. 2007; 110: 1880-1888.
26. Gross CP, Smith BD, Wolf E, Andersen M,. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer. 2008; 112: 900-908.
27. Shavers VL, Brown ML,. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334-357.
28. Brawley OW,. Is race really a negative prognostic factor for cancer? J Natl Cancer Inst. 2009; 101: 970-971.
29. LaVeist TA,. Disentangling race and socioeconomic status: a key to understanding health inequalities. J Urban Health. 2005; 82 (2 suppl 3): iii26-iii34.
30. Vona-Davis L, Rose DP,. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt). 2009; 18: 883-893.
31. Komenaka IK, Martinez ME, Pennington RE Jr, et al. Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst. 2010; 102: 1178-1187.
32. Bradley CJ, Given CW, Roberts C,. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002; 94: 490-496.
33. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA,. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006; 24: 1342-1349.
34. Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL,. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009; 101: 984-992.
35. Farrow DC, Hunt WC, Samet JM,. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992; 326: 1097-1101.
36. Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG,. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 1996; 88: 716-726.
37. Du Xianglin L, Gor BJ,. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis. 2007; 17: 122-128.
38. Hershman DL, Buono D, McBride RB, et al. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst. 2008; 100: 199-206.
39. Lund MJ, Brawley OP, Ward KC, Young JL, Gabram SS, Eley JW,. Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat. 2008; 109: 545-557.
40. Sariego J,. Regional variation in breast cancer treatment throughout the United States. Am J Surg. 2008; 196: 572-574.
41. Freedman RA, He Y, Winer EP, Keating NL,. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol. 2009; 27: 713-719.
42. Smith GL, Shih YC, Xu Y, et al. Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study. Cancer. 2010; 116: 734-741.
43. Dragun AE, Huang B, Tucker TC, Spanos WJ,. Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: impact on overall survival. Cancer. 2011; 117: 2590-2598.
44. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004; 351: 971-977.
45. Schwartz GF, Veronesi U, Clough KB, et al. Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy. Cancer. 2006; 107: 242-250.
46. Hughes KS, Schnaper LA, Cirrincione C, Berry D,. Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer [abstract]. J Clin Oncol. 2010; 28 (69s). Abstract 207.
47. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366: 2087-2106.
48. Maly RC, Stein JA, Umezawa Y, Leake B, Anglin MD,. Racial/ethnic differences in breast cancer outcomes among older patients: effects of physician communication and patient empowerment. Health Psychol. 2008; 27: 728-736.
49. Keating NL, Kouri E, He Y, Weeks JC, Winer EP,. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care. 2009; 47: 765-773.
50. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR,. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000; 92: 269-271.
51. Voti L, Richardson LC, Reis I, Fleming LE, Mackinnon J, Coebergh JW,. The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida. Breast Cancer Res Treat. 2006; 95: 89-95.
52. Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI,. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer. 2005; 103: 2241-2251.
53. Li CI, Daling JR, Malone KE,. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol. 2003; 21: 28-34.
54. Dunnwald LK, Rossing MA, Li CI,. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007; 9: R6.
55. Krieger N, Chen JT, Ware JH, Kaddour A,. Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control. 2008; 19: 1305-1318.
56. Malin JL, Kahn KL, Adams J, Kwan L, Laouri M, Ganz PA,. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst. 2002; 94: 835-844.